At present, many clinical prognostic biomarkers are available for HCC, such as alpha-fetoprotein (AFP), alpha-fetoprotein lens culinaris agglutin-3 (AFP-L3), and des-γ-carboxy prothrombin (DCP). The gene discussed is AFP; the disease is hepatocellular carcinoma.